Influence of gender and age on haematological indicators of Polbar’s breed chickens

The aim of the study was to determine the values of selected haematological indices of the Polbar breed of chickens by gender and age. There was a significant WBC difference in cocks and hens with age. In each of the periods, cocks were characterized by a lower than hens number of LY. LY and NE declined with increasing age. Most values showed significant (P ≤ 0.05) differences for birds at different ages. These results of the haematological indices from consolidated Polbar breed can be used for comparisons with other breeds of poultry. The study deepens and organizes the knowledge within the possibilities of using and interpreting levels of haematological indicators for monitoring health of hens. In this paper, we managed to obtain information on the level of indicators rarely determined in chickens

Phytobiotics, a Natural Growth Promoter for Poultry

Genetic advance aimed at accelerating the growth rate of slaughter birds have reduced the natural resistance of poultry to infections. It also increased susceptibility to stress, which resulted in deterioration of the welfare and productivity of poultry. Additionally, intensive poultry production poses a risk of exposure of chickens to unfavorable zoo-hygienic conditions and contamination with pathogens from the external environment (bedding, water, feed, hen house staff, sick birds in the flock). Due to the potential production losses, measures are taken to improve the health and effectiveness of bird rearing, for example by using growth stimulants and improving the composition of the gastrointestinal microbiome and improving metabolism and the work of the immune system. The addition of phytobiotics to feed or drinking water supports digestion and metabolism in the body, stimulates the growth and development of a useful microbiome, limits the multiplication and adhesion of pathogens, and improves the structure and functioning of enterocytes. The aim of this study is to present the health benefits resulting from the use of phytobiotics in poultry production, as well as to make people aware of the dangers of incompetent incorporation of herbs into feed mixtures or into drinking water. Due to the fact that not all species of animals react equally to a given plant, the selection of plant materials should be carefully considered and matched to the expected benefits. By using phytobiotics you can improve growth and performance of broiler chickens, through greatly improve digestion and nutrient assimilation. Plant additives can improve health through stimulate immunity and increase resistance to stress. Using of phitobiotics improve the quality of meat and eggs, increase the weight of valuable parts of carcass (pectoral and leg muscles) and stimulate laying. Unfortunately, due to the potentially toxic effect of an excess of certain herbs on the work of the liver, and the adverse changes in the palatability of eggs, use caution in the use some herbs e.g. of garlic, turmeric, rapeseed, alfa alfa, shiny privet or moringa

TLC-densitometric analysis of allantoin in Symphytum officinale L. roots

A TLC-densitometric method for determination of allantoin in Symphytum officinale root was developed. Densitometric quantification of allantoin was carried out on TLC Si60 plates with butanol-50 % methanol-formic acid, 66.5:33.2:0.3 (V/V/V) as developing solvent, at a wavelength of 190 nm. The method was preliminarily validated in terms of specificity, linearity, precision, limit of detection, limit of quantification, recovery and robustness. The results of TLC quantification were compared with HPLC analysis carried out on a HILIC Luna NH2 100A column, with mobile phase consisting of acetonitrile-water 80:20 (V/V) and UV detection at 190 and 210 nm. Allantoin content was determined in two herbal products and it varied from 0.94 to 2.09 %, depending on the producer, and was in agreement with literature reports

Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial

Aims The objective of the Aliskiren Trial on Acute Heart Failure Outcomes (ASTRONAUT) was to determine whether aliskiren, a direct renin inhibitor, would improve post-discharge outcomes in patients with hospitalization for heart failure (HHF) with reduced ejection fraction. Pre-specified subgroup analyses suggested potential heterogeneity in post-discharge outcomes with aliskiren in patients with and without baseline diabetes mellitus (DM). Methods and results ASTRONAUT included 953 patients without DM (aliskiren 489; placebo 464) and 662 patients with DM (aliskiren 319; placebo 343) (as reported by study investigators). Study endpoints included the first occurrence of cardiovascular death or HHF within 6 and 12 months, all-cause death within 6 and 12 months, and change from baseline in N-terminal pro-B-type natriuretic peptide (NT-proBNP) at 1, 6, and 12 months. Data regarding risk of hyperkalaemia, renal impairment, and hypotension, and changes in additional serum biomarkers were collected. The effect of aliskiren on cardiovascular death or HHF within 6 months (primary endpoint) did not significantly differ by baseline DM status (P = 0.08 for interaction), but reached statistical significance at 12 months (non-DM: HR: 0.80, 95% CI: 0.64-0.99; DM: HR: 1.16, 95% CI: 0.91-1.47; P = 0.03 for interaction). Risk of 12-month all-cause death with aliskiren significantly differed by the presence of baseline DM (non-DM: HR: 0.69, 95% CI: 0.50-0.94; DM: HR: 1.64, 95% CI: 1.15-2.33; P < 0.01 for interaction). Among non-diabetics, aliskiren significantly reduced NT-proBNP through 6 months and plasma troponin I and aldosterone through 12 months, as compared to placebo. Among diabetic patients, aliskiren reduced plasma troponin I and aldosterone relative to placebo through 1 month only. There was a trend towards differing risk of post-baseline potassium ≥6 mmol/L with aliskiren by underlying DM status (non-DM: HR: 1.17, 95% CI: 0.71-1.93; DM: HR: 2.39, 95% CI: 1.30-4.42; P = 0.07 for interaction). Conclusion This pre-specified subgroup analysis from the ASTRONAUT trial generates the hypothesis that the addition of aliskiren to standard HHF therapy in non-diabetic patients is generally well-tolerated and improves post-discharge outcomes and biomarker profiles. In contrast, diabetic patients receiving aliskiren appear to have worse post-discharge outcomes. Future prospective investigations are needed to confirm potential benefits of renin inhibition in a large cohort of HHF patients without D

Desmoid krezki jelita cienkiego u chorej po proktokolektomii odtwórczej z powodu z rodzinnej polipowatości jelita grubego – opis przypadku

Desmoid (desmoid tumor) to cytologicznie łagodny nowotwór włóknisty pochodzący ze struktur mięśniowo-ścięgnistych całego ciała [1]. Termin „desmoid”, wprowadzony po raz pierwszy przez Mullera w 1838 roku, pochodzi od greckiego słowa desmos, co oznacza ścięgnisty [2]. Etiopatogeneza desmoidu nie jest do końca poznana, większość doniesień i publikacji dotyczących jego leczenia oparta jest na pojedynczych opisach przypadków. Rokowanie jest dobre, a wyleczenie uzyskuję się głównie poprzez chirurgiczne wycięcie zmiany. Celem pracy jest przedstawienie przypadku 33-letniej chorej z rozpoznaną rodzinną polipowatością jelita grubego, u której stwierdzono występowanie desmoidu krezki jelita cienkiego

Assessment of Neurodegenerative Changes in Turkeys Fed Diets with Different Proportions of Arginine and Methionine Relative to Lysine

We postulated that the use of optimal levels and proportions of Arg and Met relative to a low or high concentration of Lys in diets for meat turkeys would reduce the occurrence of metabolic disturbances in the nervous tissue that can lead to neurodegenerative changes. The aim of the study was to determine the effect of various proportions of Lys, Arg, and Met in diets for turkeys, with a low content of Lys in accordance with NRC (Experiment 1) recommendations, and in diets with high Lys levels that are close to the recommendations of breeding companies (Experiment 2) on selected indicators of potential neurodegenerative effects in the brain and liver of turkeys. The Experiment 1 and Experiment 2 was conducted using 864 day-old turkey chicks randomly assigned to six groups, in eight replicates (6 groups &times; 18 birds &times; 8 replicates). A full description of the methodology can be found in previously published papers using the same experimental design. Indicators informing about the presence or advancement of neurodegenerative processes in the nervous tissue were determined in the brain and liver (level of: AChE, amyloid-&beta;, GAChE, Tau protein, LRP1, and the degree of DNA methylation). It was established that in the case of both a low (National Research Council, NRC) and a high (British United Turkeys, BUT) level of Lys in the diet of turkeys, the Arg level can be reduced to 90% of the Lys level and Met to 30% of the Lys level, because this does not cause neurodegenerative changes in turkeys. Unfavorable neurodegenerative changes may appear if the Arg level is increased from 100 to 110% of the Lys level recommended by the NRC. However, due to the lack of such a relationship when Arg is increased from 100 to 110% of the Lys level recommended by BUT, at this stage of research no definitive conclusions can be drawn regarding the risk of neurodegenerative changes caused by increasing Arg in the diet of turkeys

Desmoid tumor of the mesentery in a patient after restorative proctocolectomy as a result of familial adenomatous polyposis – case reports

Desmoid (desmoid tumor) is a cytologically benign fibrous tumor that originates from musculoskeletal structures of the entire body [1]. The term „desmoid”, first introduced by Muller in 1838, derives from the Greek word desmos, which means tendinous [2]. The etiopathogenesis of desmoid is not fully understood, most reports of publications regarding its treatment are based on individual case reports. The prognosis is good, and healing is achieved mainly through surgical excision of the lesion. The aim of the paper is to present a case of a 33-year-old woman with diagnosed familial polyposis in the colon, who has been identified with mesenteric desmoid

Desmoid tumor of the mesentery in a patient after restorative proctocolectomy as a result of familial adenomatous polyposis – case reports

Desmoid (desmoid tumor) is a cytologically benign fibrous tumor that originates from musculoskeletal structures of the entire body [1]. The term „desmoid”, first introduced by Muller in 1838, derives from the Greek word desmos, which means tendinous [2]. The etiopathogenesis of desmoid is not fully understood, most reports of publications regarding its treatment are based on individual case reports. The prognosis is good, and healing is achieved mainly through surgical excision of the lesion. The aim of the paper is to present a case of a 33-year-old woman with diagnosed familial polyposis in the colon, who has been identified with mesenteric desmoid